Is Adicet Bio, Inc. (ACET) a Buy, Sell, or Hold?
Adicet Bio, Inc.
NASDAQ:ACET
$8.7 USD
-$0.13 (-1.47%)
- Volume
- 40.62K
- Average Volume
- 108.61K
- Market Capitalization
- $81.33M
- P/E Ratio
- -0.58
- Dividend Yield
- 0.00%
- Price Target
- $432.00
- Year High
- $17.44
- Year Low
- $6.01
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $7.65
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
30
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
9
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 358.03K
ACET Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
ACET Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Schor Chen | director, officer: President & CEO | 2026-06-19 | A-Award | 8.1 | 2026-06-23 |
| Aftab Blake | officer: Chief Scientific Officer | 2026-06-19 | A-Award | 8.1 | 2026-06-23 |
| DUBIN STEVE | director | 2026-06-21 | A-Award | 8.1 | 2026-06-23 |
| Chodakewitz Jeffrey | director | 2026-06-21 | A-Award | 8.1 | 2026-06-23 |
| Grissinger Michael | director | 2026-06-21 | A-Award | 8.1 | 2026-06-23 |
| Sinclair Andrew | director | 2026-06-21 | A-Award | 8.1 | 2026-06-23 |
| Peng Katie | director | 2026-06-21 | A-Award | 8.1 | 2026-06-23 |
| Klickstein Lloyd | director | 2026-06-21 | A-Award | 8.1 | 2026-06-23 |
| RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 2026-04-27 | J-Other | 0.0001 | 2026-04-29 |
| RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 2026-04-27 | J-Other | 0.0001 | 2026-04-29 |
| RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 2026-02-20 | P-Purchase | 7.27 | 2026-04-13 |
| RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 2026-02-19 | P-Purchase | 7.21 | 2026-04-13 |
| RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 2026-02-18 | P-Purchase | 7.04 | 2026-04-13 |
| RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 2026-02-17 | 0 | 2026-04-13 | |
| RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 2026-02-17 | 0.0001 | 2026-04-13 | |
| ORBIMED ADVISORS LLC | 10 percent owner | 2026-04-07 | S-Sale | 6.53 | 2026-04-09 |
| ORBIMED ADVISORS LLC | 10 percent owner | 2026-04-07 | S-Sale | 6.38 | 2026-04-09 |
| ORBIMED ADVISORS LLC | 10 percent owner | 2026-04-08 | S-Sale | 6.29 | 2026-04-09 |
| ORBIMED ADVISORS LLC | 10 percent owner | 2026-04-08 | S-Sale | 6.52 | 2026-04-09 |
| Harvey Brian Nicholas | officer: Chief Financial Officer | 2026-03-25 | A-Award | 6.81 | 2026-03-27 |
| Schor Chen | director, officer: President & CEO | 2026-03-25 | A-Award | 6.81 | 2026-03-27 |
| Maltzman Julia D. | officer: Chief Medical Officer | 2026-03-25 | A-Award | 6.81 | 2026-03-27 |
| Healey Don | officer: Chief Technology Officer | 2026-03-25 | A-Award | 6.81 | 2026-03-27 |
| Aftab Blake | officer: Chief Scientific Officer | 2026-03-25 | A-Award | 6.81 | 2026-03-27 |
| Aftab Blake | officer: Chief Scientific Officer | 2026-01-24 | F-InKind | 8.44 | 2026-01-27 |
| Healey Don | officer: Chief Technology Officer | 2026-01-24 | F-InKind | 8.44 | 2026-01-27 |
| Schor Chen | director, officer: President & CEO | 2026-01-24 | F-InKind | 8.44 | 2026-01-27 |
| Harvey Brian Nicholas | officer: Chief Financial Officer | 2026-01-24 | F-InKind | 8.44 | 2026-01-27 |
| ORBIMED ADVISORS LLC | 10 percent owner | 2025-10-08 | P-Purchase | 1 | 2025-10-10 |
| ORBIMED ADVISORS LLC | 10 percent owner | 2025-10-08 | P-Purchase | 1 | 2025-10-10 |
| Klickstein Lloyd | director | 2025-06-11 | A-Award | 0 | 2025-06-13 |
| Klickstein Lloyd | director | 2025-06-11 | A-Award | 0.78 | 2025-06-13 |
| Chodakewitz Jeffrey | director | 2025-06-11 | A-Award | 0.78 | 2025-06-13 |
| Chodakewitz Jeffrey | director | 2025-06-11 | A-Award | 0 | 2025-06-13 |
| DUBIN STEVE | director | 2025-06-11 | A-Award | 0.78 | 2025-06-13 |
| DUBIN STEVE | director | 2025-06-11 | A-Award | 0 | 2025-06-13 |
| Peng Katie | director | 2025-06-11 | A-Award | 0.78 | 2025-06-13 |
| Peng Katie | director | 2025-06-11 | A-Award | 0 | 2025-06-13 |
| Sinclair Andrew | director | 2025-06-11 | A-Award | 0.78 | 2025-06-13 |
| Sinclair Andrew | director | 2025-06-11 | A-Award | 0 | 2025-06-13 |
| Grissinger Michael | director | 2025-04-17 | A-Award | 0.5258 | 2025-04-21 |
| Grissinger Michael | 2025-04-17 | 0 | 2025-04-21 | ||
| Aftab Blake | officer: Chief Scientific Officer | 2025-01-31 | A-Award | 0.885 | 2025-02-04 |
| Schor Chen | director, officer: President & CEO | 2025-01-31 | A-Award | 0.885 | 2025-02-04 |
| Healey Don | officer: Chief Technology Officer | 2025-01-31 | A-Award | 0.885 | 2025-02-04 |
| Maltzman Julia D. | officer: Chief Medical Officer | 2025-01-31 | A-Award | 0.885 | 2025-02-04 |
| Harvey Brian Nicholas | officer: Chief Financial Officer | 2025-01-31 | A-Award | 0.885 | 2025-02-04 |
| Schor Chen | director, officer: President & CEO | 2025-01-24 | F-InKind | 0.9218 | 2025-01-28 |
| Healey Don | officer: Chief Technology Officer | 2025-01-24 | F-InKind | 0.9218 | 2025-01-28 |
| Aftab Blake | officer: Chief Scientific Officer | 2025-01-24 | F-InKind | 0.9218 | 2025-01-28 |
| Harvey Brian Nicholas | officer: Chief Financial Officer | 2025-01-24 | F-InKind | 0.9218 | 2025-01-28 |
| Maltzman Julia D. | 2025-01-13 | 0 | 2025-01-23 | ||
| Sinclair Andrew | director | 2024-08-21 | A-Award | 15.75 | 2024-08-23 |
| Sinclair Andrew | director | 2024-08-21 | A-Award | 5.195 | 2024-08-23 |
| Sinclair Andrew | director | 2024-08-21 | A-Award | 15.93 | 2024-08-23 |
| Sinclair Andrew | director | 2024-08-21 | A-Award | 11.49 | 2024-08-23 |
| Sinclair Andrew | director | 2024-08-21 | A-Award | 15.93 | 2024-08-23 |
| Sinclair Andrew | director | 2024-08-21 | D-Return | 2.14 | 2024-08-23 |
| GORDON CARL L | director, 10 percent owner: | 2024-08-21 | A-Award | 16.11 | 2024-08-23 |
| GORDON CARL L | director, 10 percent owner: | 2024-08-21 | A-Award | 5.195 | 2024-08-23 |
| GORDON CARL L | director, 10 percent owner: | 2024-08-21 | A-Award | 15.93 | 2024-08-23 |
| GORDON CARL L | director, 10 percent owner: | 2024-08-21 | A-Award | 11.49 | 2024-08-23 |
| GORDON CARL L | director, 10 percent owner: | 2024-08-21 | D-Return | 2.14 | 2024-08-23 |
| Peng Katie | director | 2024-08-21 | A-Award | 3.38 | 2024-08-23 |
| Peng Katie | director | 2024-08-21 | D-Return | 2.14 | 2024-08-23 |
| Chodakewitz Jeffrey | director | 2024-08-21 | A-Award | 16.11 | 2024-08-23 |
| Chodakewitz Jeffrey | director | 2024-08-21 | A-Award | 5.195 | 2024-08-23 |
| Chodakewitz Jeffrey | director | 2024-08-21 | A-Award | 15.93 | 2024-08-23 |
| Chodakewitz Jeffrey | director | 2024-08-21 | A-Award | 11.49 | 2024-08-23 |
| Chodakewitz Jeffrey | director | 2024-08-21 | D-Return | 2.14 | 2024-08-23 |
| DUBIN STEVE | director | 2024-08-21 | A-Award | 16.11 | 2024-08-23 |
| DUBIN STEVE | director | 2024-08-21 | A-Award | 5.195 | 2024-08-23 |
| DUBIN STEVE | director | 2024-08-21 | A-Award | 11.49 | 2024-08-23 |
| DUBIN STEVE | director | 2024-08-21 | A-Award | 15.93 | 2024-08-23 |
| DUBIN STEVE | director | 2024-08-21 | D-Return | 2.14 | 2024-08-23 |
| Kauffman Michael | director | 2024-08-21 | A-Award | 9.39 | 2024-08-23 |
| Kauffman Michael | director | 2024-08-21 | A-Award | 5.195 | 2024-08-23 |
| Kauffman Michael | director | 2024-08-21 | A-Award | 11.49 | 2024-08-23 |
| Kauffman Michael | director | 2024-08-21 | D-Return | 2.14 | 2024-08-23 |
| Jakobovits Aya | director | 2024-08-21 | A-Award | 16.11 | 2024-08-23 |
| Jakobovits Aya | director | 2024-08-21 | A-Award | 5.195 | 2024-08-23 |
| Jakobovits Aya | director | 2024-08-21 | A-Award | 15.93 | 2024-08-23 |
| Jakobovits Aya | director | 2024-08-21 | A-Award | 11.49 | 2024-08-23 |
| Jakobovits Aya | director | 2024-08-21 | D-Return | 2.14 | 2024-08-23 |
| Klickstein Lloyd | director | 2024-08-19 | A-Award | 1.55 | 2024-08-20 |
| Klickstein Lloyd | director | 2024-08-19 | 0 | 2024-08-20 | |
| Klickstein Lloyd | director | 2024-08-19 | 2.14 | 2024-08-20 | |
| Aftab Blake | officer: Chief Scientific Officer | 2024-06-05 | A-Award | 2.53 | 2024-06-07 |
| Galimi Francesco | officer: SVP & Chief Medical Officer | 2024-06-05 | A-Award | 2.53 | 2024-06-07 |
| Harvey Brian Nicholas | officer: Chief Financial Officer | 2024-06-05 | A-Award | 2.53 | 2024-06-07 |
| Healey Don | officer: Chief Technology Officer | 2024-06-05 | A-Award | 2.53 | 2024-06-07 |
| Schor Chen | director, officer: President & CEO | 2024-06-05 | A-Award | 2.53 | 2024-06-07 |
| GORDON CARL L | director, 10 percent owner: | 2024-06-05 | A-Award | 1.44 | 2024-06-07 |
| GORDON CARL L | director, 10 percent owner: | 2024-06-05 | A-Award | 0 | 2024-06-07 |
| Chodakewitz Jeffrey | director | 2024-06-05 | A-Award | 1.44 | 2024-06-07 |
| Chodakewitz Jeffrey | director | 2024-06-05 | A-Award | 0 | 2024-06-07 |
| Jakobovits Aya | director | 2024-06-05 | A-Award | 1.44 | 2024-06-07 |
| Jakobovits Aya | director | 2024-06-05 | A-Award | 0 | 2024-06-07 |
| DUBIN STEVE | director | 2024-06-05 | A-Award | 1.44 | 2024-06-07 |
| DUBIN STEVE | director | 2024-06-05 | A-Award | 0 | 2024-06-07 |